CSIMarket Company Name, Ticker, Suppliers, else..



Worst Performing Stocks In Medical Equipment & Supplies Industry During This Current Quarter Q2 Of 2025


 1 Day   Week  Current Month of April  30 Days 
Current Quarter Q2 of 2025  90 Days    Ytd    12 Months 
 

Shares fell by -9.72% on average, in Medical Equipment & Supplies Industry during this current quarter q2 of 2025.

Here are the Worst performing stocks in Medical Equipment & Supplies Industry.




STSS

$0.0217

$-1.7183 -98.75%
This Quarter Q2 of 2025


STSS

$0.0217

$-1.7183 -98.75%



Sharps Technology Inc

Sharps Technology Inc shares dropped -98.75% during this current quarter q2 of 2025.


Sharps Technology Inc operates as a technology solutions provider, offering a range of products and services to businesses in various industries. Their business model is focused on developing and delivering innovative technological solutions tailored to meet their clients* specific needs and requirements. By leveraging their expertise, they aim to help businesses enhance efficiency, productivity, and overall performance through the implementation of cutting-edge technological solutions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.027 mill. $ - mill. $ -0.917 mill. 1 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.027 mill.
$ - mill.


$ -0.917 mill.
Employees Shares Outstanding P/E

22
1 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


OBIO

$2.54

$-2.9700 -53.90%
This Quarter Q2 of 2025


OBIO

$2.54

$-2.9700 -53.90%



Orchestra Biomed Holdings Inc

Orchestra Biomed Holdings Inc shares dropped -53.90% during this current quarter q2 of 2025.


Orchestra Biomed Holdings Inc is a medical technology company that primarily focuses on the development and commercialization of innovative therapies for cardiac diseases. Their business model revolves around identifying unmet needs in the cardiovascular market, developing novel therapeutic solutions, and bringing them to market through strategic partnerships and collaborations.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 93.374 mill. $ 2.638 mill. $ -61.024 mill. 37 mill. - Y/Y -3.44 %
Market Cap. Revenues TTM Net Income TTM

$ 93.374 mill.
$ 2.638 mill.


$ -61.024 mill.
Employees Shares Outstanding P/E

11
37 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -3.44 %
MRQ Y/Y - %


OMI

$6.96

$-7.8700 -53.07%
This Quarter Q2 of 2025


OMI

$6.96

$-7.8700 -53.07%



Owens and Minor inc

Owens And Minor Inc shares dropped -53.07% during this current quarter q2 of 2025.


Owens and Minor Inc operates as a global healthcare solutions company. Their business model primarily involves sourcing, manufacturing, and distributing medical supplies and equipment to healthcare providers. The company aims to optimize the supply chain, reduce costs for healthcare facilities, and improve patient care through their comprehensive distribution network.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 533.677 mill. $ 10,700.155 mill. $ -362.686 mill. 77 mill. - Y/Y 1.52 %
Market Cap. Revenues TTM Net Income TTM

$ 533.677 mill.
$ 10,700.155 mill.


$ -362.686 mill.
Employees Shares Outstanding P/E

13,700
77 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 1.52 %
MRQ Y/Y - %


VVOS

$2.48

$-2.2300 -47.35%
This Quarter Q2 of 2025


VVOS

$2.48

$-2.2300 -47.35%



Vivos Therapeutics Inc

Vivos Therapeutics Inc stock went down -47.35% during this current quarter q2 of 2025.


Vivos Therapeutics Inc employs a business model that focuses on providing innovative solutions for the treatment of breathing-related sleep disorders.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 12.440 mill. $ 15.019 mill. $ -11.136 mill. 5 mill. - Y/Y 49.12 %
Market Cap. Revenues TTM Net Income TTM

$ 12.440 mill.
$ 15.019 mill.


$ -11.136 mill.
Employees Shares Outstanding P/E

50
5 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 49.12 %
MRQ Y/Y - %


SMLR

$34.74

$-26.4100 -43.19%
This Quarter Q2 of 2025


SMLR

$34.74

$-26.4100 -43.19%



Semler Scientific Inc

Semler Scientific Inc shares declined -43.19% during this current quarter q2 of 2025.


Semler Scientific Inc*s business model revolves around providing medical diagnostic and testing devices, specifically focusing on vascular health.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 276.965 mill. $ 56.294 mill. $ 40.899 mill. 8 mill. 7.05 Y/Y -17.55 %
Market Cap. Revenues TTM Net Income TTM

$ 276.965 mill.
$ 56.294 mill.


$ 40.899 mill.
Employees Shares Outstanding P/E

31
8 mill.
7.05
Revenue Growth Income Growth

MRQ Y/Y -17.55 %
MRQ Y/Y 591.92 %


SRTS

$4.63

$-2.3800 -33.95%
This Quarter Q2 of 2025


SRTS

$4.63

$-2.3800 -33.95%



Sensus Healthcare Inc

Sensus Healthcare Inc stock went down -33.95% during this current quarter q2 of 2025.


Sensus Healthcare Inc operates through a business model centered around the development, manufacturing, and marketing of advanced medical devices, primarily focused on providing non-invasive treatments for various skin conditions and cancers. The company aims to deliver effective and efficient solutions to healthcare providers, enabling them to deliver exceptional patient care and improve outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 75.062 mill. $ 41.431 mill. $ 6.647 mill. 16 mill. 11.47 Y/Y 225.55 %
Market Cap. Revenues TTM Net Income TTM

$ 75.062 mill.
$ 41.431 mill.


$ 6.647 mill.
Employees Shares Outstanding P/E

35
16 mill.
11.47
Revenue Growth Income Growth

MRQ Y/Y 225.55 %
MRQ Y/Y - %


VTAK

$0.29

$-0.1370 -32.08%
This Quarter Q2 of 2025


VTAK

$0.29

$-0.1370 -32.08%



Catheter Precision Inc

Catheter Precision Inc shares declined -32.08% during this current quarter q2 of 2025.


Catheter Precision Inc is a medical device manufacturing company that specializes in the production of catheters and related components. The company follows a business-to-business (B2B) model, supplying its products to healthcare institutions, hospitals, and other medical device companies. With its focus on precision and quality, Catheter Precision Inc aims to provide innovative and reliable solutions for various medical procedures involving catheters.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.946 mill. $ 0.420 mill. $ -21.801 mill. 3 mill. - Y/Y 16.41 %
Market Cap. Revenues TTM Net Income TTM

$ 0.946 mill.
$ 0.420 mill.


$ -21.801 mill.
Employees Shares Outstanding P/E

50
3 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 16.41 %
MRQ Y/Y - %


VERO

$2.6985

$-1.2461 -31.59%
This Quarter Q2 of 2025


VERO

$2.6985

$-1.2461 -31.59%



Venus Concept Inc

Venus Concept Inc shares dropped -31.59% during this current quarter q2 of 2025.


Venus Concept Inc*s business model focuses on offering innovative and effective medical aesthetic devices and technology solutions to healthcare professionals.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.781 mill. $ 50.306 mill. $ -46.971 mill. 1 mill. - Y/Y -11.45 %
Market Cap. Revenues TTM Net Income TTM

$ 1.781 mill.
$ 50.306 mill.


$ -46.971 mill.
Employees Shares Outstanding P/E

292
1 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -11.45 %
MRQ Y/Y - %


XRAY

$13.62

$-5.8200 -29.94%
This Quarter Q2 of 2025


XRAY

$13.62

$-5.8200 -29.94%



Dentsply Sirona Inc

Dentsply Sirona Inc shares dropped -29.94% during this current quarter q2 of 2025.


Dentsply Sirona Inc operates as a leading provider of dental solutions by manufacturing and distributing a wide range of dental equipment, consumables, and digital dentistry products. Their business model emphasizes innovation and research, aiming to enhance dental practice efficiency and improve patient outcomes. By prioritizing customer-centric strategies, they support dental professionals in delivering high-quality care through advanced technologies and comprehensive product offerings.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2,766.563 mill. $ 3,793.000 mill. $ -910.000 mill. 203 mill. - Y/Y -4.44 %
Market Cap. Revenues TTM Net Income TTM

$ 2,766.563 mill.
$ 3,793.000 mill.


$ -910.000 mill.
Employees Shares Outstanding P/E

15,000
203 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -4.44 %
MRQ Y/Y - %


STAA

$17.61

$-6.3400 -26.47%
This Quarter Q2 of 2025


STAA

$17.61

$-6.3400 -26.47%



Staar Surgical Co

Staar Surgical Co shares went down -26.47% during this current quarter q2 of 2025.


Staar Surgical Co employs a business model focused on developing, manufacturing, and distributing implantable lenses used for the treatment of refractive errors such as myopia and astigmatism. The company primarily sells its products to eye surgeons and ophthalmologists globally, generating revenue through product sales and royalties from licensing agreements. By constantly innovating and expanding its product portfolio, Staar Surgical Co aims to improve vision outcomes for patients and maintain a competitive position in the ophthalmic market.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 867.958 mill. $ 313.901 mill. $ -20.208 mill. 49 mill. - Y/Y -35.82 %
Market Cap. Revenues TTM Net Income TTM

$ 867.958 mill.
$ 313.901 mill.


$ -20.208 mill.
Employees Shares Outstanding P/E

1,115
49 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -35.82 %
MRQ Y/Y - %


TFX

$135.11

$-45.6300 -25.25%
This Quarter Q2 of 2025


TFX

$135.11

$-45.6300 -25.25%



Teleflex Incorporated

Teleflex Incorporated shares went down -25.25% during this current quarter q2 of 2025.


Teleflex Incorporated operates with a diversified business model centered on the design, development, manufacturing, and distribution of specialty medical devices across various medical fields, including critical care, surgical, and respiratory care. The company is committed to delivering innovative and high-quality medical technologies that enhance patient outcomes and improve procedural efficiency for healthcare professionals worldwide.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 6,360.668 mill. $ 3,046.679 mill. $ 69.675 mill. 47 mill. 94.80 Y/Y 2.85 %
Market Cap. Revenues TTM Net Income TTM

$ 6,360.668 mill.
$ 3,046.679 mill.


$ 69.675 mill.
Employees Shares Outstanding P/E

14,500
47 mill.
94.80
Revenue Growth Income Growth

MRQ Y/Y 2.85 %
MRQ Y/Y - %


OSUR

$3.02

$-0.9700 -24.31%
This Quarter Q2 of 2025


OSUR

$3.02

$-0.9700 -24.31%



Orasure Technologies Inc

Orasure Technologies Inc shares declined -24.31% during this current quarter q2 of 2025.


Orasure Technologies Inc*s business model revolves around the development, manufacturing, and distribution of innovative diagnostic products, primarily in the field of oral fluid diagnostics.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 226.500 mill. $ 185.390 mill. $ -19.500 mill. 75 mill. - Y/Y -49.24 %
Market Cap. Revenues TTM Net Income TTM

$ 226.500 mill.
$ 185.390 mill.


$ -19.500 mill.
Employees Shares Outstanding P/E

501
75 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -49.24 %
MRQ Y/Y - %


VSEE

$1.19

$-0.3800 -24.20%
This Quarter Q2 of 2025


VSEE

$1.19

$-0.3800 -24.20%



Vsee Health inc

Vsee Health Inc shares went down -24.20% during this current quarter q2 of 2025.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 17.942 mill. $ 5.066 mill. $ -55.942 mill. 15 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 17.942 mill.
$ 5.066 mill.


$ -55.942 mill.
Employees Shares Outstanding P/E

100
15 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


OFIX

$13.96

$-4.3200 -23.63%
This Quarter Q2 of 2025


OFIX

$13.96

$-4.3200 -23.63%



Orthofix Medical Inc

Orthofix Medical Inc shares went down -23.63% during this current quarter q2 of 2025.


Orthofix Medical Inc is a company that focuses on developing and selling medical devices and orthopedic solutions to healthcare providers and patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 533.005 mill. $ 798.885 mill. $ -125.997 mill. 38 mill. - Y/Y 8.01 %
Market Cap. Revenues TTM Net Income TTM

$ 533.005 mill.
$ 798.885 mill.


$ -125.997 mill.
Employees Shares Outstanding P/E

1,271
38 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 8.01 %
MRQ Y/Y - %


USPH

$69.51

$-21.3700 -23.51%
This Quarter Q2 of 2025


USPH

$69.51

$-21.3700 -23.51%



U S Physical Therapy Inc

U S Physical Therapy Inc stock declined -23.51% during this current quarter q2 of 2025.


U.S. Physical Therapy Inc operates as a healthcare services provider specializing in outpatient rehabilitation services. The company*s business model revolves around operating and managing physical therapy clinics across the United States, offering a range of services to help patients recover from injuries, surgeries, and other physical conditions. U.S. Physical Therapy Inc generates revenue by billing insurance companies and patients for the services provided at its clinics.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1,187.110 mill. $ 671.345 mill. $ 45.600 mill. 17 mill. 37.77 Y/Y 31.02 %
Market Cap. Revenues TTM Net Income TTM

$ 1,187.110 mill.
$ 671.345 mill.


$ 45.600 mill.
Employees Shares Outstanding P/E

6,720
17 mill.
37.77
Revenue Growth Income Growth

MRQ Y/Y 31.02 %
MRQ Y/Y -32.39 %


UFPT

$205.76

$-56.7500 -21.62%
This Quarter Q2 of 2025


UFPT

$205.76

$-56.7500 -21.62%



Ufp Technologies Inc

Ufp Technologies Inc stock went down -21.62% during this current quarter q2 of 2025.


UFP Technologies Inc*s business model involves the manufacturing and customization of innovative, foam-based solutions for various industries.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1,601.046 mill. $ 503.693 mill. $ 58.981 mill. 8 mill. 27.21 Y/Y 43.51 %
Market Cap. Revenues TTM Net Income TTM

$ 1,601.046 mill.
$ 503.693 mill.


$ 58.981 mill.
Employees Shares Outstanding P/E

401
8 mill.
27.21
Revenue Growth Income Growth

MRQ Y/Y 43.51 %
MRQ Y/Y 41.07 %


SRDX

$29.67

$-7.8300 -20.88%
This Quarter Q2 of 2025


SRDX

$29.67

$-7.8300 -20.88%



Surmodics Inc

Surmodics Inc stock went down -20.88% during this current quarter q2 of 2025.


Surmodics Inc operates on a business model centered around the development and commercialization of innovative medical device and pharmaceutical technologies. The company focuses on creating surface modification technologies, such as drug delivery coatings, that enhance the performance and functionality of medical devices and improve therapeutic outcomes. Surmodics Inc collaborates with industry partners to license or directly manufacture and sell their proprietary products in various medical fields.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 422.234 mill. $ 122.773 mill. $ -11.744 mill. 14 mill. - Y/Y -46.18 %
Market Cap. Revenues TTM Net Income TTM

$ 422.234 mill.
$ 122.773 mill.


$ -11.744 mill.
Employees Shares Outstanding P/E

389
14 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -46.18 %
MRQ Y/Y - %


SMTI

$31.41

$-6.7100 -17.60%
This Quarter Q2 of 2025


SMTI

$31.41

$-6.7100 -17.60%



Sanara Medtech Inc

Sanara Medtech Inc shares dropped -17.60% during this current quarter q2 of 2025.


Sanara Medtech Inc*s business model focuses on developing and providing innovative medical technologies and solutions for wound care, aiming to improve patient outcomes and address unmet needs in the healthcare industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 266.284 mill. $ 86.533 mill. $ -9.912 mill. 8 mill. - Y/Y 57.83 %
Market Cap. Revenues TTM Net Income TTM

$ 266.284 mill.
$ 86.533 mill.


$ -9.912 mill.
Employees Shares Outstanding P/E

141
8 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 57.83 %
MRQ Y/Y - %


ISRG

$508.41

$-100.2500 -16.47%
This Quarter Q2 of 2025


ISRG

$508.41

$-100.2500 -16.47%



Intuitive Surgical Inc

Intuitive Surgical Inc stock dropped -16.47% during this current quarter q2 of 2025.


Intuitive Surgical Incs business model focuses on delivering robotic surgical systems, particularly the da Vinci Surgical System, which facilitates minimally invasive surgeries. Revenue is generated through system sales, instruments, accessories, and services, including training and maintenance for healthcare providers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 185,366.286 mill. $ 8,713.500 mill. $ 2,493.800 mill. 365 mill. 74.75 Y/Y 19.17 %
Market Cap. Revenues TTM Net Income TTM

$ 185,366.286 mill.
$ 8,713.500 mill.


$ 2,493.800 mill.
Employees Shares Outstanding P/E

13,676
365 mill.
74.75
Revenue Growth Income Growth

MRQ Y/Y 19.17 %
MRQ Y/Y 28.55 %


UTMD

$52.8517

$-9.8983 -15.77%
This Quarter Q2 of 2025


UTMD

$52.8517

$-9.8983 -15.77%



Utah Medical Products Inc

Utah Medical Products Inc shares declined -15.77% during this current quarter q2 of 2025.


Utah Medical Products Inc*s business model revolves around the manufacturing and sale of medical devices and equipment.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 173.890 mill. $ 39.228 mill. $ 13.615 mill. 3 mill. 13.74 Y/Y -46.34 %
Market Cap. Revenues TTM Net Income TTM

$ 173.890 mill.
$ 39.228 mill.


$ 13.615 mill.
Employees Shares Outstanding P/E

155
3 mill.
13.74
Revenue Growth Income Growth

MRQ Y/Y -46.34 %
MRQ Y/Y -48.69 %


BDX

$204.12

$-36.3500 -15.12%
This Quarter Q2 of 2025


BDX

$204.12

$-36.3500 -15.12%



Becton Dickinson And Company

Becton Dickinson And Company shares dropped -15.12% during this current quarter q2 of 2025.


Becton Dickinson and Company operates a business model focused on developing and providing advanced medical technologies, including a diverse portfolio of medical devices and diagnostic products. Their strategy emphasizes innovation, quality, and strategic partnerships to enhance patient care and streamline healthcare processes across various settings.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 59,469.577 mill. $ 20,640.000 mill. $ 1,727.000 mill. 291 mill. 34.38 Y/Y 9.82 %
Market Cap. Revenues TTM Net Income TTM

$ 59,469.577 mill.
$ 20,640.000 mill.


$ 1,727.000 mill.
Employees Shares Outstanding P/E

74,000
291 mill.
34.38
Revenue Growth Income Growth

MRQ Y/Y 9.82 %
MRQ Y/Y 7.83 %


VANI

$1.0304

$-0.1696 -14.13%
This Quarter Q2 of 2025


VANI

$1.0304

$-0.1696 -14.13%



Vivani Medical Inc

Vivani Medical Inc stock declined -14.13% during this current quarter q2 of 2025.


Vivani Medical Inc is a medical device company that focuses on the development, manufacturing, and distribution of innovative healthcare products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 56.279 mill. $ - mill. $ -23.486 mill. 55 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 56.279 mill.
$ - mill.


$ -23.486 mill.
Employees Shares Outstanding P/E

-
55 mill.
-
Revenue Growth Income Growth

MRQ Y/Y - %
MRQ Y/Y - %


HSIC

$65.86

$-8.8900 -11.89%
This Quarter Q2 of 2025


HSIC

$65.86

$-8.8900 -11.89%



Henry Schein Inc

Henry Schein Inc stock declined -11.89% during this current quarter q2 of 2025.


Henry Schein Inc operates as a global distributor of healthcare products, services, and technology solutions, primarily targeting dental and medical professionals. Their business model emphasizes a vast network of sales consultants and a diverse product range from various manufacturers, aiming to deliver high-quality products, innovative solutions, and exceptional customer service to enhance patient care and improve practice efficiency.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 8,421.443 mill. $ 12,673.000 mill. $ 398.000 mill. 128 mill. 21.56 Y/Y 5.77 %
Market Cap. Revenues TTM Net Income TTM

$ 8,421.443 mill.
$ 12,673.000 mill.


$ 398.000 mill.
Employees Shares Outstanding P/E

19,000
128 mill.
21.56
Revenue Growth Income Growth

MRQ Y/Y 5.77 %
MRQ Y/Y 464.71 %


OM

$11.39

$-1.5100 -11.71%
This Quarter Q2 of 2025


OM

$11.39

$-1.5100 -11.71%



Outset Medical Inc

Outset Medical Inc stock dropped -11.71% during this current quarter q2 of 2025.


Outset Medical Inc*s business model revolves around the production and distribution of innovative medical devices for kidney dialysis. With a focus on patient-centric care, their flagship product Tablo simplifies dialysis and allows for it to be performed in various clinical settings, including hospitals, clinics, and homes. By offering a comprehensive solution that combines hardware, software, and support services, Outset Medical aims to improve the dialysis experience for both healthcare providers and patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 39.503 mill. $ 113.564 mill. $ -127.976 mill. 3 mill. - Y/Y 3.50 %
Market Cap. Revenues TTM Net Income TTM

$ 39.503 mill.
$ 113.564 mill.


$ -127.976 mill.
Employees Shares Outstanding P/E

480
3 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 3.50 %
MRQ Y/Y - %


STXS

$1.99

$-0.2200 -9.95%
This Quarter Q2 of 2025


STXS

$1.99

$-0.2200 -9.95%



Stereotaxis Inc

Stereotaxis Inc stock declined -9.95% during this current quarter q2 of 2025.


Stereotaxis Inc*s business model involves developing and providing robotic technologies for use in medical procedures, particularly in the field of electrophysiology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 168.175 mill. $ 26.594 mill. $ -24.045 mill. 85 mill. - Y/Y 61.50 %
Market Cap. Revenues TTM Net Income TTM

$ 168.175 mill.
$ 26.594 mill.


$ -24.045 mill.
Employees Shares Outstanding P/E

139
85 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 61.50 %
MRQ Y/Y - %


SSKN

$2.6317

$-0.2783 -9.56%
This Quarter Q2 of 2025


SSKN

$2.6317

$-0.2783 -9.56%



Strata Skin Sciences Inc

Strata Skin Sciences Inc shares declined -9.56% during this current quarter q2 of 2025.


Strata Skin Sciences Inc*s business model revolves around developing and marketing innovative medical devices and products for dermatology and aesthetic procedures.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 10.016 mill. $ 34.749 mill. $ -12.827 mill. 4 mill. - Y/Y 39.68 %
Market Cap. Revenues TTM Net Income TTM

$ 10.016 mill.
$ 34.749 mill.


$ -12.827 mill.
Employees Shares Outstanding P/E

106
4 mill.
-
Revenue Growth Income Growth

MRQ Y/Y 39.68 %
MRQ Y/Y - %


ZBH

$100.9261

$-10.0839 -9.08%
This Quarter Q2 of 2025


ZBH

$100.9261

$-10.0839 -9.08%



Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc stock declined -9.08% during this current quarter q2 of 2025.


Zimmer Biomet Holdings Inc operates as a global leader in musculoskeletal healthcare, focusing on the design, manufacture, and marketing of innovative medical devices for joint replacement, sports medicine, spine, and dental implants. Their business model emphasizes improving patient outcomes and advancing the field through advanced surgical products and solutions targeted at healthcare professionals worldwide.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 20,590.747 mill. $ 7,678.600 mill. $ 905.300 mill. 204 mill. 22.67 Y/Y 4.29 %
Market Cap. Revenues TTM Net Income TTM

$ 20,590.747 mill.
$ 7,678.600 mill.


$ 905.300 mill.
Employees Shares Outstanding P/E

18,000
204 mill.
22.67
Revenue Growth Income Growth

MRQ Y/Y 4.29 %
MRQ Y/Y -42.79 %


SOLV

$67.21

$-6.3900 -8.68%
This Quarter Q2 of 2025


SOLV

$67.21

$-6.3900 -8.68%



Solventum Corporation

Solventum Corporation stock went down -8.68% during this current quarter q2 of 2025.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 11,664.344 mill. $ 8,254.000 mill. $ 479.000 mill. 174 mill. 24.38 Y/Y -74.86 %
Market Cap. Revenues TTM Net Income TTM

$ 11,664.344 mill.
$ 8,254.000 mill.


$ 479.000 mill.
Employees Shares Outstanding P/E

-
174 mill.
24.38
Revenue Growth Income Growth

MRQ Y/Y -74.86 %
MRQ Y/Y -93.53 %


SYK

$360.04

$-33.4600 -8.50%
This Quarter Q2 of 2025


SYK

$360.04

$-33.4600 -8.50%



Stryker Corp

Stryker Corp stock went down -8.50% during this current quarter q2 of 2025.


Stryker Corps business model focuses on innovation in medical technologies and devices, specializing in areas such as orthopedics, surgical equipment, and neurotechnology, to enhance patient care and improve outcomes in the healthcare industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 139,083.452 mill. $ 22,595.000 mill. $ 2,993.000 mill. 386 mill. 46.40 Y/Y 10.68 %
Market Cap. Revenues TTM Net Income TTM

$ 139,083.452 mill.
$ 22,595.000 mill.


$ 2,993.000 mill.
Employees Shares Outstanding P/E

52,000
386 mill.
46.40
Revenue Growth Income Growth

MRQ Y/Y 10.68 %
MRQ Y/Y -52.23 %


BAX

$30.17

$-2.2800 -7.03%
This Quarter Q2 of 2025


BAX

$30.17

$-2.2800 -7.03%



Baxter International Inc

Baxter International Inc shares went down -7.03% during this current quarter q2 of 2025.


Baxter International Inc is a global healthcare company that specializes in providing a wide range of medical products and services. They operate through various business segments including Pharmaceuticals, Medical Products, and Renal Care, offering solutions for hospitals, clinics, and home-based healthcare settings.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 15,417.583 mill. $ 10,636.000 mill. $ -638.000 mill. 511 mill. - Y/Y -85.78 %
Market Cap. Revenues TTM Net Income TTM

$ 15,417.583 mill.
$ 10,636.000 mill.


$ -638.000 mill.
Employees Shares Outstanding P/E

41,000
511 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -85.78 %
MRQ Y/Y - %


MMM

$139.48

$-10.1500 -6.78%
This Quarter Q2 of 2025


MMM

$139.48

$-10.1500 -6.78%



3m Company

3m Company shares dropped -6.78% during this current quarter q2 of 2025.


3M Company operates a diversified business model by offering innovative solutions across multiple segments, including healthcare, safety and industrial, transportation, and consumer goods. The company leverages its extensive portfolio of patents and deep customer relationships to drive product development and market responsiveness, focusing on delivering value across various industries.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 76,393.196 mill. $ 24,513.000 mill. $ 4,377.000 mill. 548 mill. 17.60 Y/Y -25.60 %
Market Cap. Revenues TTM Net Income TTM

$ 76,393.196 mill.
$ 24,513.000 mill.


$ 4,377.000 mill.
Employees Shares Outstanding P/E

85,000
548 mill.
17.60
Revenue Growth Income Growth

MRQ Y/Y -25.60 %
MRQ Y/Y 20.26 %


PODD

$260.86

$-16.3400 -5.89%
This Quarter Q2 of 2025


PODD

$260.86

$-16.3400 -5.89%



Insulet Corporation

Insulet Corporation stock dropped -5.89% during this current quarter q2 of 2025.


Insulet Corporation operates under a business model where they design, develop, and market innovative tubeless insulin delivery systems for people with diabetes. Their main product, the Omnipod System, is a wearable device that provides continuous insulin delivery without the need for traditional insulin pumps and tubing. This unique business model focuses on improving the quality of life for individuals with diabetes by offering a convenient and user-friendly insulin management solution.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 18,878.501 mill. $ 2,071.600 mill. $ 418.300 mill. 72 mill. 45.34 Y/Y 17.20 %
Market Cap. Revenues TTM Net Income TTM

$ 18,878.501 mill.
$ 2,071.600 mill.


$ 418.300 mill.
Employees Shares Outstanding P/E

3,000
72 mill.
45.34
Revenue Growth Income Growth

MRQ Y/Y 17.20 %
MRQ Y/Y -2.52 %


MDT

$84.26

$-4.9900 -5.59%
This Quarter Q2 of 2025


MDT

$84.26

$-4.9900 -5.59%



Medtronic Plc

Medtronic Plc stock went down -5.59% during this current quarter q2 of 2025.


Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 108,375.212 mill. $ 33,199.000 mill. $ 4,290.000 mill. 1,286 mill. 25.58 Y/Y 2.51 %
Market Cap. Revenues TTM Net Income TTM

$ 108,375.212 mill.
$ 33,199.000 mill.


$ 4,290.000 mill.
Employees Shares Outstanding P/E

100,000
1,286 mill.
25.58
Revenue Growth Income Growth

MRQ Y/Y 2.51 %
MRQ Y/Y -2.54 %


BSX

$101.21

$-0.4300 -0.42%
This Quarter Q2 of 2025


BSX

$101.21

$-0.4300 -0.42%



Boston Scientific Corporation

Boston Scientific Corporation stock declined -0.42% during this current quarter q2 of 2025.


Boston Scientific Corporations business model centers on creating innovative medical devices for diverse specialties, aimed at addressing unmet medical needs and enhancing patient outcomes. The company sells its products to healthcare professionals and hospitals globally, supported by robust sales and distribution networks. It prioritizes research and development to continually introduce new technologies and solutions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 150,033.704 mill. $ 16,747.000 mill. $ 1,846.000 mill. 1,482 mill. 81.23 Y/Y 22.44 %
Market Cap. Revenues TTM Net Income TTM

$ 150,033.704 mill.
$ 16,747.000 mill.


$ 1,846.000 mill.
Employees Shares Outstanding P/E

48,000
1,482 mill.
81.23
Revenue Growth Income Growth

MRQ Y/Y 22.44 %
MRQ Y/Y 11.71 %


STVN

$21.89

$0.4500 2.10%
This Quarter Q2 of 2025


STVN

$21.89

$0.4500 2.10%



Stevanato Group S p a

Stevanato Group S P A stock increased 2.10% during this current quarter q2 of 2025.


Stevanato Group S.p.a is a global provider of packaging and drug delivery solutions for the pharmaceutical industry. The company specializes in the design and manufacturing of glass containers, syringes, cartridges, and other primary packaging components. They also offer comprehensive services including drug delivery devices and analytical testing, ensuring end-to-end support for pharmaceutical companies.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 5,796.114 mill. $ 1,215.596 mill. $ 163.173 mill. 265 mill. 35.54 Y/Y 10.34 %
Market Cap. Revenues TTM Net Income TTM

$ 5,796.114 mill.
$ 1,215.596 mill.


$ 163.173 mill.
Employees Shares Outstanding P/E

5,000
265 mill.
35.54
Revenue Growth Income Growth

MRQ Y/Y 10.34 %
MRQ Y/Y 1.87 %


STE

$226.525

$9.3250 4.29%
This Quarter Q2 of 2025


STE

$226.525

$9.3250 4.29%



Steris Plc

Steris Plc stock improved 4.29% during this current quarter q2 of 2025.


Steris Plc operates in the healthcare industry by providing comprehensive infection prevention, decontamination, surgical, and critical care solutions designed for healthcare providers, including hospitals and pharmaceutical manufacturers. Their business model focuses on delivering a diverse array of innovative products, services, and software that enhance safety, efficiency, and overall patient outcomes in medical environments.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 22,462.737 mill. $ 5,398.371 mill. $ 468.997 mill. 99 mill. 48.09 Y/Y -1.80 %
Market Cap. Revenues TTM Net Income TTM

$ 22,462.737 mill.
$ 5,398.371 mill.


$ 468.997 mill.
Employees Shares Outstanding P/E

18,000
99 mill.
48.09
Revenue Growth Income Growth

MRQ Y/Y -1.80 %
MRQ Y/Y 22.95 %


SNN

$26.76

$1.7700 7.08%
This Quarter Q2 of 2025


SNN

$26.76

$1.7700 7.08%



Smith and Nephew Plc

Smith And Nephew Plc stock went up 7.08% during this current quarter q2 of 2025.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 23,381.661 mill. $ 5,549.000 mill. $ 263.000 mill. 874 mill. 88.90 Y/Y 0.00 %
Market Cap. Revenues TTM Net Income TTM

$ 23,381.661 mill.
$ 5,549.000 mill.


$ 263.000 mill.
Employees Shares Outstanding P/E

18,300
874 mill.
88.90
Revenue Growth Income Growth

MRQ Y/Y 0.00 %
MRQ Y/Y 0.00 %


PEN

$296.395

$22.6150 8.26%
This Quarter Q2 of 2025


PEN

$296.395

$22.6150 8.26%



Penumbra Inc

Penumbra Inc stock increased 8.26% during this current quarter q2 of 2025.


Penumbra Inc operates on a business model that focuses on the development and manufacturing of innovative medical devices. They aim to provide cutting-edge technologies and solutions to improve patient outcomes in various medical fields. The company primarily generates revenue through the sales of their medical devices to healthcare professionals and institutions worldwide.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 11,607.844 mill. $ 1,240.100 mill. $ 42.233 mill. 39 mill. 282.54 Y/Y 16.32 %
Market Cap. Revenues TTM Net Income TTM

$ 11,607.844 mill.
$ 1,240.100 mill.


$ 42.233 mill.
Employees Shares Outstanding P/E

4,200
39 mill.
282.54
Revenue Growth Income Growth

MRQ Y/Y 16.32 %
MRQ Y/Y 256.51 %


SPAI

$3.95

$0.4400 12.54%
This Quarter Q2 of 2025


SPAI

$3.95

$0.4400 12.54%



Safe Pro Group Inc

Safe Pro Group Inc stock increased 12.54% during this current quarter q2 of 2025.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 41.918 mill. $ 4.075 mill. $ -14.857 mill. 11 mill. - Y/Y -99.57 %
Market Cap. Revenues TTM Net Income TTM

$ 41.918 mill.
$ 4.075 mill.


$ -14.857 mill.
Employees Shares Outstanding P/E

-
11 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -99.57 %
MRQ Y/Y - %


PAVM

$0.77

$0.1588 25.98%
This Quarter Q2 of 2025


PAVM

$0.77

$0.1588 25.98%



Pavmed Inc

Pavmed Inc shares improved 25.98% during this current quarter q2 of 2025.


Pavmed Inc is a medical device company that focuses on developing and commercializing innovative products for various medical fields. The company*s business model revolves around identifying unmet medical needs, acquiring proprietary rights to potential products, and advancing them through development stages to obtain regulatory approvals and market them.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 49.228 mill. $ 3.249 mill. $ 28.427 mill. 64 mill. - Y/Y -98.95 %
Market Cap. Revenues TTM Net Income TTM

$ 49.228 mill.
$ 3.249 mill.


$ 28.427 mill.
Employees Shares Outstanding P/E

25
64 mill.
-
Revenue Growth Income Growth

MRQ Y/Y -98.95 %
MRQ Y/Y - %



 1 Day   Week  Current Month of April  30 Days 
Current Quarter Q2 of 2025  90 Days    Ytd    12 Months 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com